This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Xianglin Shi
Principal Scientist at Biogen


Xianglin Shi received a B.S. in chemistry from Yanan University and a M.S. from Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences. He obtained his Ph.D. from Emory University under the direction of Prof. Lanny S. Liebeskind. As a process chemist, he worked at Rhodia Chirex, Millennium Pharmaceuticals, and Biogen and was involved in process R&D, scale-up, and manufacturing. In his most recent roles in Biogen, he is responsible for oligonucleotide chemical process development including solid-supported and solution-phase synthesis, and involved in process validation, manufacturing, and worldwide regulatory filing including Spinraza.

Agenda Sessions

  • ROOM 204AB: Development of a Scalable Synthesis Process for Oligonucleotides